Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Innovative intraoral cooling device better tolerated and equally effective as ice cooling
Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.
Univ West, Trollhättan, Sweden.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Haematology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Caring Sciences.ORCID iD: 0000-0003-2960-4994
Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.
2017 (English)In: Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, E-ISSN 1432-0843, Vol. 80, no 5, p. 965-972Article in journal (Refereed) Published
Abstract [en]

Most of the patients who receive myeloablative therapy prior to stem cell transplantation develop oral mucositis (OM). This adverse reaction manifests as oral mucosal erythema and ulcerations and may require high doses of morphine for pain alleviation. OM may also interfere with food intake and result in weight loss, a need for parenteral nutrition, and impaired quality of life. To date, there have been very few studies of evidence-based interventions for the prevention of OM. Cryotherapy, using ice chips, has been shown to reduce in an efficient manner the severity and extent of OM, although clinical applications are still limited due to several shortcomings, such as adverse tooth sensations, problems with infectious organisms in the water, nausea, and uneven cooling of the oral mucosa. The present proof-of-concept study was conducted to compare the tolerability, temperature reduction, and cooling distribution profiles of an intra-oral cooling device and ice chips in healthy volunteers who did not receive myeloablative treatment, and therefore, did not experience the symptoms of OM. Twenty healthy volunteers used the cooling device and ice chips for a maximum of 60 min each, using a cross-over design. The baseline and final temperatures were measured at eight intra-oral locations using an infra-red thermographic camera. The thermographic images were analysed using two digital software packages. A questionnaire was used to assess the tolerability levels of the two interventions. The intra-oral cooling device was significantly better tolerated than the ice-chips (p = 0.0118). The two interventions were equally effective regarding temperature reduction and cooling distribution. The intra-oral cooling device shows superior tolerability in healthy volunteers. Furthermore, this study shows that temperature reduction and cooling distribution are achieved equally well using either method.

Place, publisher, year, edition, pages
2017. Vol. 80, no 5, p. 965-972
Keywords [en]
Cryotherapy, Tolerability, Healthy volunteers, Intra-oral cooling device, Oral mucositis, Myeloablative therapy
National Category
Cancer and Oncology Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:uu:diva-341946DOI: 10.1007/s00280-017-3434-2ISI: 000414762300009PubMedID: 28975429OAI: oai:DiVA.org:uu-341946DiVA, id: diva2:1183296
Funder
Stiftelsen Assar Gabrielssons fond, FB16-04Wilhelm och Martina Lundgrens Vetenskapsfond, 2016-0986
Note

A Correction to this article was published on 30 October 2017. Correction to: Cancer Chemother Pharmacol DOI 10.1007/s00280-017-3434-2Unfortunately, the online published article has error in Table 1.

Available from: 2018-02-16 Created: 2018-02-16 Last updated: 2023-07-07Bibliographically approved

Open Access in DiVA

fulltext(698 kB)167 downloads
File information
File name FULLTEXT01.pdfFile size 698 kBChecksum SHA-512
6087973ef6c8c54fd33338ce721c53afd85df7766ea80e4d1873a54311fb8dce81eb4d25744fee46ff0a15e3f1a52dc2eebe75d8413b36f3f9f4290906c33067
Type fulltextMimetype application/pdf
errata(462 kB)7 downloads
File information
File name ERRATA01.pdfFile size 462 kBChecksum SHA-512
94eb7511499df142bd17e03c625480cf201f43ef64b4e09d8d6fade19fa16e6eb46ae04de44765aa8bc9333404542e8b09b461d625680b4cc4a8734fd386ef7a
Type errataMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Svanberg, Anncarin
By organisation
HaematologyCaring Sciences
In the same journal
Cancer Chemotherapy and Pharmacology
Cancer and OncologyPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
Total: 167 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 91 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf